| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Selling > Sellers See Light At The End Of The Tunnel |
|
Answers - Sellers See Light At The End Of The Tunnel
We`ve been discussing on several blogs the essence of "Pricing a home to sell". As the market According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product has changed so has the marketing and listing of a home. Today overpricing a home won`t accompl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in sh anything except keeping the home on the market for a very long time! Case in point: Two m lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. onths ago we had a buyer make an offer on a home located in Oklawaha,Florida. The home is sit here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ated on an a small lake and the seller was asking $245,000. The Comps in the area didn`t justi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro fy the price and we made what we thought was a very reasonable offer based on the recent sales ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc in the area. Our offer of $192,000 was indeed rejected and the seller refused to counter. We easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi spoke to the buyer and told him that we should notify the seller to keep our offer and if any nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hing changes, contact us. The home was listed on the market for almost 9 months which as many and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ of you know the longer a home remains on the market the harder it becomes to sell it! I kept ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi n eye on the listing each week and noticed on Monday that the seller decided to lower their pr ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ice to $224,900. I was convinced that the seller was finally "motivated to sell". I called the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod buyer and asked if they were still interested in the home, and they responded with a resoundin cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin g YES! This time I explained to our buyer that our offer needs to be bumped up a few points. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen fter careful deliberation the buyers instructed me to offer $210,000. The offer was submitte t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d to the other agent and the seller accepted the offer within 5 hours! The agent explained to ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e that the seller remembered what we mentioned to them 60 days ago, in regards to "How the ma y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rket has changed" and it`s all about price, he realized that of he didn`t do something soon, h . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s home would just remain on the market with no hope of selling and that wasn`t an option. Mor elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e and more we`re seeing this happen, it appears that many sellers are finally seeing the light tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:3C's + 3M's = Effective Communication Start Your Internet Business by Using a Niche Debt Consolidation At Low Interest Rate!!!
|